MedPath

Treatment of Badhirya(Sensory Neural Hearing Loss)with Bilwadi taila Karnapurana and Sarivadi vati with and without Shadabindu taila Nasya

Phase 3
Not yet recruiting
Conditions
Health Condition 1: H832- Labyrinthine dysfunction
Registration Number
CTRI/2020/12/029899
Lead Sponsor
IPGT and RA Gujarat Ayurved UniversityJamnagar
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Patients in the age group 18-60 years irrespective of sex, caste, religion etc.

Degree of hearing loss (Between 25 dB to 90 dB Sensory Neural Hearing Loss)

Exclusion Criteria

Age :- below 18 year and above 60 year Degree of hearing loss greater than 90 dB

Conductive deafness

Mixed hearing loss

Middle ear pathology

Inner ear pathology like Acoustic Neuroma, Meniereâ??s disease.

Genetic Sensory Neural Hearing Loss

Syphilitic Sensory Neural Hearing Loss

Psychogenic hearing loss

Systemic diseases: e.g. Diabetes, Hypothyroidism, Renal disorders, Autoimmune disorders, Multiple sclerosis.

Malignancy.

Patient who need surgical intervention

ï??

Age :- below 18 year and above 60 year

Degree of hearing loss greater than 90 dB Conductive deafness

Mixed hearing loss

Middle ear pathology

Inner ear pathology like Acoustic Neuroma, Meniereâ??s disease.

Genetic Sensory Neural Hearing Loss

Syphilitic Sensory Neural Hearing Loss

Psychogenic hearing loss

Systemic diseases: e.g. Diabetes, Hypothyroidism, Renal disorders, Autoimmune disorders, Multiple sclerosis.

Malignancy.

Patient who need surgical intervention

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Relief in sign and symptoms of Badhirya after 4 weeksTimepoint: Relief in sign and symptoms of Badhirya after 4 weeks
Secondary Outcome Measures
NameTimeMethod
Improvement in quality of life and social wellbeing of PatientsTimepoint: within 4 weeks from the trial
© Copyright 2025. All Rights Reserved by MedPath